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Background: Extended-spectrum β-lactamase (ESBL)-encoding genes are frequently
mapped to plasmids, yet few of these structures have been characterized at the molecular
level, to date.
Methods: Eighty-seven ESBL-producing Escherichia coli were isolated from fecal
samples of food-producing animals and healthy humans in Switzerland from 2009 to 2011.
Plasmid DNA of all isolates was purified. Broth mating assays were carried out individually
for 32 isolates to determine if the ESBL marker could be transferred by conjugation. The
plasmid sizes were determined by S1-nuclease pulsed-field gel electrophoresis (PFGE)
and the plasmids were typed by PCR-based replicon typing. Susceptibility tests by
disk diffusion followed with a re-analysis S1-nuclease PFGE and PCRs were performed
to confirm plasmid transfer. Microarray was performed to detect additional antibiotic
resistance markers and multi-locus sequence typing was also performed in selected donor
strains. The phylotypes were identified by triplex PCR.
Results: About half (n = 46) of the 87 isolates carried small (<20-kb) plasmids. All
selected 32 isolates contained large plasmids (ranging in sizes from 20- to 600-kb). Eleven
plasmid replicon types were detected. Of these, IncFIA (n = 5), IncFIB (n = 9), and
IncK/B (n = 4) were common. Nine isolates demonstrated the ability to transfer their
cefotaxime resistance marker at high transfer rates. Plasmid profile re-analysis of these
transconjugants identified 16 plasmids. IncFIB and IncI1 were the most prevalent replicon
types. Phylogenetic grouping showed that five of the nine donor strains belonged to
phylogroup B1. Nine different sequence types were identified in nine tested donor strains.
Conclusion: Characterization of these ESBL-encoding conjugative plasmids extends our
understanding on these resistance markers in multi-drug resistant E. coli cultured from
healthy human and animal sources.
Keywords: ESBLs, E. coli, horizontal gene transfer, replicon typing, conjugation, S1-nuclease PFGE, plasmid
profiling, plasmids
INTRODUCTION
Global dissemination of multiple antibiotic resistance and viru-
lence traits by plasmids poses an increasing threat to the successful
treatment of bacterial infectious diseases in animals and humans
alike (Bush, 2010). Extended-spectrum β-lactamase (ESBL) pro-
ducing Escherichia coli has become one of the most important
causes of nosocomial and community acquired infections (Coque
et al., 2008; Foxman, 2013) and most of the ESBL enzymes rec-
ognized are expressed from genes mapped to plasmids (Paterson
and Bonomo, 2005; Garcillan-Barcia et al., 2011). It is acknowl-
edged that the horizontal transfer of plasmids carrying these ESBL
genes is an important contributory factor in the epidemiology
of this bacterial ecosystem (EFSA Panel on Biological Hazards
[BIOHAZ], 2011). The predominant ESBL families of clinical
importance include TEM, SHV, and CTX-M (Bush and Jacoby,
2010); and the genes conferring this resistance phenotype in ani-
mals include blaCTX−M−1 (the most frequently identified ESBL),
blaCTX−M−14, blaTEM−52, and blaSHV−12 (EFSA Panel on Biologi-
calHazards [BIOHAZ],2011). E. coli is themost commonbacterial
species identified with these genes.
Plasmids evolve as an integral part of the bacterial genome, con-
sisting of several extra-chromosomal traits, one of which is their
resistance genes, which can be exchanged among bacteria of dif-
ferent origins by conjugation (Carattoli, 2011). Those expressing
an ESBL phenotype frequently carry genes encoding resistance to
other commonly used antimicrobial drug classes (such as amino-
glycosides, chloramphenicols, fluoroquinolones, or tetracycline;
Harajly et al., 2010; Rogers et al., 2011). Plasmid-mediated transfer
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of drug-resistance genes among various bacterial species is con-
sidered to be one of the most important mechanisms driving
the spread of multi-drug resistance (MDR) markers. The use of
antimicrobial compounds in human and veterinary medicine also
constitutes a risk factor for the selection and dissemination of
resistant clones, and also plasmids containing the corresponding
resistance genes. Consequently, these features limit the treatment
options available when ESBL-producing organisms are encoun-
tered. Therefore, as a first step to address this problem, it is
important to monitor the dissemination of ESBL-producing bac-
teria, characterizing these microbes when they arise. Moreover,
studies describing the genetic basis of plasmids derived from bac-
teria recovered from animals, humans, and the environment are
essential.
Extended-spectrum-β-lactamase transmission is mainly driven
by insertion sequences, transposons, integrons, and plasmids,
some of which are homologous in isolates from both food pro-
ducing animals and humans (van Hoek et al., 2011; Stalder et al.,
2012). Plasmid-encoded genes can arise from multiple sources
(Boyd et al., 1996) being subsequently disseminated by horizontal
gene transfer (HGT). HGT is responsible for the dissemination
of many traits associated with bacteria, including antibiotic resis-
tance and virulence. In addition, broad-host-range plasmids play
an important role in bacterial adaptation to new environments.
Taken together these characteristics provide much of the motiva-
tion of extending our understanding of the structural relationships
that exist between plasmids from a variety of bacterial sources.
Following the dissemination routes of antibiotic resistance genes
on ESBL-harboring plasmids is important to broaden our knowl-
edge of how these genes are shared horizontally across species
boundaries as well as their evolution (Zhou et al., 2012). Moreover,
characterization based on plasmid profiling and the definition
of corresponding incompatibility (Inc) group is an integral part
of plasmid epidemiological surveillance enhancing discrimination
between E. coli strains (Carattoli et al., 2005).
In this paper, we report on the preliminary characterization
of ESBL-producing E. coli isolates that were originally described
following culture and phenotypic studies in healthy humans and
animals in Switzerland. The aims of this study were (i) to iden-
tify the plasmids relating to ESBL markers, (ii) to characterize the
donor E. coli isolates by phylogenetic grouping and multi-locus
sequence typing (MLST), and (iii) to determine the replicon types
and S1 nuclease-based plasmid profiles, following pulsed-field
gel electrophoresis (PFGE). The epidemiological data presented
extends our understanding of this resistance type in humans and
animals.
MATERIALS AND METHODS
BACTERIAL STUDY STRAINS COLLECTIONS
Extended-spectrum-β-lactamase-producing E. coli (n = 87) were
cultured from fecal samples of healthy humans (n = 34) and
healthy food-producing animals (n = 52) in Switzerland, as well
as one from a mastitis milk sample. To prevent sample cluster-
ing, at most two animal samples per farm were taken throughout
Switzerland. All human samples were collected in urban areas, and
each individual was tested only once. Prior to testing, all isolates
were streaked for purity on MacConkey agar (Oxoid, Basingstoke,
England). The protocols for collecting and isolating the strains
were described previously (Geser et al., 2012a,b).
PLASMID PROFILING
Plasmid DNAs from all isolates were purified using the WizardR
Plus SV DNA Purification System (Promega, Madison, WI, USA)
according to the manufacturer’s instructions, followed by sepa-
ration in a 0.8% (w/v) agarose gel (SeaKemR LE Agarose, Lonza
Wokingham Ltd, UK) staining with GelRedTM (Biotium, Hay-
ward, CA, USA). S1-nuclease (Promega, Madison, WI, USA)
digestion as well as PFGE analysis were performed for selected 32
isolates basedon their small plasmid subgroups and corresponding
ESBL genotypes reported previously (the complete isolate infor-
mation is listed in Figure A1 in Appendix). Briefly, the procedure
included a lysis stepof thebacterial cells embedded in agaroseplugs
followed by digestion with 8 U S1 nuclease at 37◦C for 45 min.
Finally, each plasmid sample was resolved by PFGE in a Chef-
Mapper® XA System (Bio-Rad, USA) at 14◦C, with a switch time
between 1 and 12 s, at 6 V/cm on a 120◦ angle in 0.5× TBE buffer
for 18 h. Each DNA band was considered a unit length of linear
plasmid (Barton et al., 1995). The approximate molecular mass
of plasmids was determined by comparing with E. coli 39R 861,
containing four reference plasmids, of known molecular weights
6.9-, 36-, 63-, and 147-kb (Macrina et al., 1978).
PCR-BASED REPLICON TYPING
Plasmids were assigned to incompatibility groups on the basis
of the presence of specific replicon sequences identified by PCR
using the primers previously designed and the corresponding
amplification protocols described (Carattoli et al., 2005).
CONJUGATION-BASED MATING EXPERIMENTS AND VERIFICATION
Thirty-two selected isolates were analyzed individually, for their
ability to transfer cefotaxime resistance to a rifampicin-resistant,
plasmid-free E. coli recipient (26R 793). Conjugation experiments
were carried out using a broth mating protocol. Transconju-
gants were selected on Luria-Bertani (LB) agar plates (Difco
Laboratories, Becton Dickinson, Sparks, MD, USA) contain-
ing 4 μg/ml cefotaxime (Thermo Fisher Scientific Inc., USA)
and 100 μg/ml rifampicin (Sigma, Dublin, Ireland). Transfer
frequencies were calculated per donor cell. Susceptibility tests
were performed to confirm the plasmid transfer as described
below, followed by S1-nuclease PFGE and PCR-based replicon
typing (PBRT) to test which plasmids and resistance markers were
transferred.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Donor strains and the corresponding transconjugants were
tested for their susceptibility to a panel of antimicrobial com-
pounds by disk diffusion, following recommendations of the
Clinical and Laboratory Standards Institute (CLSI). Susceptibil-
ity/resistance was interpreted according to the CLSI document
M100-S21(CLSI, 2011). The panel of antibiotic-containing disks
(Becton, Dickinson, USA) along with their abbreviated names
consisted of ampicillin (AM), amoxicillin–clavulanic acid (AMC),
chloramphenicol (C), ciprofloxacin (CIP), cefpodoxime (CPD),
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cefoxitin (FOX), cephalothin (KF), tetracycline (TE), strepto-
mycin (S), imipenem (IPM), nalidixic acid (NA), trimethoprim–
sulfamethoxazole (SXT), and trimethoprim (W). E. coli ATCCTM
25922 was included as a quality control strain. The strains
were classified as susceptible or resistant to each antimicrobial
agent. Strains giving intermediate values were considered suscep-
tible. In addition, minimal inhibitory concentrations (MICs) of
cefotaxime for donors and transconjugants combinations were
determined using E-test strips (AB Biodisk, Solna, Sweden).
DETECTION OF RESISTANCE GENES BY MICROARRAY (GENE CHIP)
A DNA microarray analysis (AMR-ve Genotyping Kit, Clon-
diag Chip Technologies, Jena, Germany) was performed with the
donor strains to detect the genes encoding resistance to aminogly-
cosides, β-lactams, chloramphenicol, erythromycin, quinolone,
sulphonamides, tetracycline, trimethoprim, and an integrase-
encoding gene (intI).
PHYLOGENETIC CLASSIFICATION
Donor isolates that transferred cefotaxime resistance to E. coli 26R
793 were classified into the four main phylogenetic groups (A,
B1, B2, and D) using a previously described triplex PCR-based
protocol (Clermont et al., 2000). Purified DNA served as a tem-
plate. Thereafter, three specific primer sets (custom-synthesized
by MWG-Biotech AG, Ebersberg, Germany) were used to identify
the following markers; chuA (279 bp), yjaA (211 bp), and tspE4
(152 bp; Clermont et al., 2000).
MULTI-LOCUS SEQUENCE TYPING
Internal amplicons of seven housekeeping genes (adk, fumC, gyrB,
icdF, mdh, purA, recA) from the donor strains were sequenced
(Wirth et al., 2006); alleles as well as sequence types (ST) were
verified using the E. coli MLST website1.
RESULTS
PLASMID PROFILING
Eighty-seven E. coli isolates were included in this study and low
molecular weight (<20-kb) plasmids could be identified by purifi-
cation and conventional agarose gel electrophoresis. About half of
the isolates (n = 46; 53%) carried several plasmids ranging in size
from approximately 2- to 20-kb, and 41 isolates (47%)were devoid
of small plasmids.
Thirty-two isolates from the original set of 87 were selected
for further study, based on their diverse plasmid profiles and
the corresponding ESBL genotypes, reported previously (Geser
et al., 2012a,b). All were assessed for the presence of large plasmids
(ranging in size from 30- to 600-kb) by S1 nuclease digestion fol-
lowed by PFGE (Barton et al., 1995). S1 nuclease plasmid analysis
revealed that all 32 contained detectable large plasmids; most pos-
sessed two plasmids (n = 13, 40.6%) and some (n = 9, 28.1%) had
three plasmids. Heterogeneity among the profiles was a common
feature noted, although most of the plasmid profiles were related
among strains isolated from particular sources. Majority of the
human isolates (n = 12, 86%) carried two or more large (≥20-kb)
plasmids and a similar situation was noted for isolates cultured
from the animal sources (n = 16, 89%; Figure 1).
1http://mlst.ucc.ie/mlst/dbs/Ecoli
PBRT OF ISOLATES EXPRESSING AN ESBL-PHENOTYPE
Eighteen plasmid replicons were detected by qualitative PBRT
(Carattoli et al., 2005) among those 32 isolates carrying large (≥20-
kb) plasmids. Replicon typing was identified 11 of 18 replicons.
Interestingly, IncFIIA, IncFrep, IncHI2, IncL/M, IncW, IncT, or
IncX types could not be detected, by PCR analysis in our collec-
tion. Nine Inc-types were identified among the isolates cultured
from healthy humans. Of these, IncFIB (n = 9), IncFIA (n = 5),
and IncK/B (n = 4) replicon types were the predominated types.
Isolates recovered from poultry group had the highest number of
IncI1 (n = 8) types. Three other replicon types were also detected
in E. coli isolates cultured form poultry and these included IncFIB
(n = 7), IncK/B (n = 4), and IncY (n = 3). When compared with
the Inc-types identified in isolates cultured from humans, repli-
con types from the animal strains were less diverse. Several isolates
were positive for more than one replicon type. The reason could
be that they possessed multiple plasmids, or a single plasmid-
encoded replication, or partitioning genes from more than one
replicon family. A summary of these features along with the cor-
responding antimicrobial resistance profiles for all 32 isolates is
shown as a heat-map in Figure 1.
CONJUGATION EXPERIMENTS WITH ESBL-PRODUCING ISOLATES
Each isolate of the 32 selected E. coli, elaborating an ESBL-
phenotype, were tested for their ability to transfer the ESBL-
resistant phenotype, by conjugation under laboratory conditions.
Nine isolates transferred the cefotaxime resistance marker to
a susceptible E. coli recipient with transfer rates ranging from
3.1 × 10−2 (in the case of L-2) to 5.7 × 10−1 (for C-49)
transconjugants per donor cell. Transconjugants recovered were
characterized as described below.
HORIZONTAL TRANSFER OF ANTIMICROBIAL RESISTANCE AND
ASSOCIATED DETERMINANTS
With the exception of E. coli H-1519 cultured from a human and
which contained two small plasmids (of 2- and 7-kb; data not
shown), none of the other smaller (<30-kb) plasmids could be
transferred to the E. coli rifampicin-resistant recipient under labo-
ratory conditions. Four isolates (H-2291, H-2332, C-59, and L-2)
were identified wherein two large plasmids were transferred via
conjugation and a further four (H-1038, C-23, C-49, and C-60)
transferred a single large plasmid only (Figure 2).
Conjugation studies and plasmid profile analysis of all
transconjugants showed that the nine isolates possessed 16 plas-
mids. Of these, 14 were large (>30-kb) plasmids and the replicon
types were also identified, by PCR. Six plasmids belonged to dif-
ferent donors and possessed IncI1 replicons. Three large plasmids
contained IncFIB replicons and two contained IncN types. Sin-
gle plasmids were typed as being members of the IncP or IncB/O
replicon families (Figure 2).
Following conjugation the antimicrobial susceptibility of all
nine transconjugants was determined by disk diffusion. In
addition to cefotaxime resistance, resistance to several non-β-
lactam-based antimicrobial compounds such as chloramphenicol,
tetracycline, trimethoprim, and trimethoprim–sulfamethoxazole
were also transferred to the recipient, suggesting that these mark-
ers are genetically linked. The MIC values recorded for all nine
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FIGURE 1 | A heat-map summary of the sources; a schematic showing
the S1 nuclease plasmid profile; ESBL present/absent profiles; the
resistance profile and the corresponding Inc plasmid type(s) for all 32
ESBL-positive E. coli previously reported from healthy food-producing
animals and humans in Switzerland. Black squares shown indicate a
feature present in that isolate denoting its original source the ESBL marker(s)
detected, its corresponding antimicrobial resistance profile and the Inc types
detected.White squares denote features that are lacking in the corresponding
bacterial isolate. Isolate numbers denotes by the grayed boxes on the left of
the heat-map indicate those bacteria that contained self-transmissible
ESBL-harboring plasmids (they are investigated further, as described in
Figure 2). Antimicrobial compounds (it is known that many ESBL producers
may appear susceptible or intermediate to certain oxyimino cephalosporins in
vitro, if CLSI criteria are applied strictly, but do not respond to the respective
therapies. Consequently, for clinical reporting these results have to be
corrected to “resistant.”) used are abbreviated as follows: AM, ampicillin;
AMC, amoxicillin–clavulanic acid; CAZ, ceftazidime; CF, cephalothin; CPD,
cefpodoxime; CIP, ciprofloxacin; CTX, cefotaxime; CXM, cefuroxime; FEP,
cefepime; GM, gentamicin; S, streptomycin; SXT, trimethoprim-
sulfamethoxazole; TE, tetracycline.
donors ranged from 96 to >256 μg/ml by cefotaxime E-test.
When these MIC values were measured for the transconju-
gants, all were recorded at 256 g/ml and in three cases there
was between a 2- to 2.7-fold increase, in this value the MICs
of transconjugants correspondingly were higher (>256 μg/ml;
Figure 2).
Twenty-eight antibiotic resistance-encoding genes were tested
on commercial microarray in all nine donor strains. Only nine
of these markers, including aadA, cat, ctx, dfr, tem, tet, strA,
strB, and sul were detected. A CTX-encoding gene was detected
in eight isolates, with an additional isolate positive for the TEM
gene. These data were subsequently confirmed by PCR and the
genes identified as blaCTX−M−1 and blaTEM−52, respectively. Five
strains were positive for the blaTEM−1 gene. Six isolates were
positive for the integrase-encoding gene (intl) associated with
class 1 integrons. The genotypes of all nine donors and their
corresponding transconjugants are summarized in Figure 2 and
Table 1.
GENOTYPING AND PHYLOGENETIC CLASSIFICATION OF NINE DONORS
All donor isolates were sub-typed by MLST and eight STs and
an unknown ST were identified (Table 1). Genotypings identified
were ST1389, ST604 (ST446 complex), ST155 (ST155 complex),
ST3174, ST295, ST10 (ST10 complex), ST1638, ST57 (ST350 com-
plex). The allele numbers of the unknown ST type were as follows:
adk 6, fumC 4, gyrB 3, icdF 1, mdh 20, purA 8, recA 44.
The nine strains harboring self-transmissible plasmids could
be assigned to phylogenetic groups A, B1, and D. Five isolates
were assigned to group B1 and two assigned to group A. While
two isolates were assigned to the D phylogenetic groups and non-
isolate belonged to group B2 (Table 1).
DISCUSSION
By definition, plasmids do not carry genes essential for the
growth of host cells under non-stressed conditions but most
plasmids confer positively selectable phenotypes including antimi-
crobial resistance genes among others (Carattoli, 2011). Plasmids
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FIGURE 2 | A heat-map showing the comparison of ESBL-positive
E. coli donors and the resultant transconjugants, characterized
on the basis of their plasmid profiles; ESBL-markers identified by
PCR; antimicrobial resistance profile; and plasmid replicon type(s).
The MIC for cefotaxime in each pairwise combination is also shown
along with the fold increase in this value. (T) in the first column typifies
the transconjugant. Black and white squares denote the presence and
absence, respectively of a particular feature. The symbol “–” signifies
no fold-change in the MIC for the transconjugant. Antimicrobial
compounds are abbreviated as follows: AM, ampicillin; AMC,
amoxicillin–clavulanic acid; C, chloramphenicol; CPD, cefpodoxime; CIP,
ciprofloxacin; CTX, cefotaxime; KF, cephalothin; NA, nalidixic acid; S,
streptomycin; SXT, trimethoprim-sulfamethoxazole; TE, tetracycline;
W, trimethoprim.
Table 1 | Summary of genotypic and phenotypic characteristics of nine ESBL-producing E. coli isolates cultured from healthy food-producing
animals and humans in Switzerland.
Isolate no. Phylogenetic
groups
Serotype MLST Plasmid(s) (kb) isolated from
transconjugants
Additional resistance determinants
identified using a commercial microarraya
H-1038 B1 O8:H21 Unknown ST 140- aadA-strA-strB-cat-dfr-sul-tet-intl
H-1519 A O2:H48 ST10 complex 2-, 7-, 80-, 100- –
H-2291 A O53:H18 ST1638 110-, 140- aadA-dfr-sul-tet-intl
H-2332 D O24:H26 ST57/ST350 complex 100-, 150- aadA-strA-strB-cat-dfr-sul-tet-intl
C-23 B1 O3:Hnt ST1389 100- –
C-49 B1 Ont:H21 ST446 complex 110- aadA-strA-strB-dfr-sul-tet-intl
C-59 B1 O86:H51 ST155 complex 110-, 150- aadA-cat-dfr-sul-tet-intl
C-60 B1 O68:H21 ST3174 complex 110- aadA-strA-strB-dfr-sul-tet-intl
L-2 D Ont:H11 ST295 50-, 100- strB-cat-sul-tet
aMethod used: Identi Bac Chip (AMR-ve Genotyping Kit, Version 05m); the symbol “–” signifies the fact that the bacterial isolate is negative for those genes included
on the commercial microarray; “Ont” denotes an isolate whose serotype was non-typable.
represent an important pool of adaptive and transferable genetic
information and large plasmids (defined as being >30-kb in size)
are commonly being capable of transferring their genetic informa-
tion in bacteria (Norman et al., 2009; Smillie et al., 2010; Williams
et al.,2013). PreviouslyE. coli isolateswere cultured fromanumber
of healthy food-producing animals and humans in Switzerland
and all expressed an ESBL-phenotype. In the collection of 32 iso-
lates which were further studied, 82 megaplasmids were identified.
Fourplasmids hadmolecular sizes ranging from200- to about 350-
kb and a further 78 (95%) were large plasmids of sizes between
50- and 200-kb were observed. The approximate molecular sizes
of plasmids were determined by comparing with the reference
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plasmids (Macrina et al., 1978). At the outset, these data suggested
that the ESBL markers may be mapped to larger sized plasmids
(50- to 200-kb).
Currently, 27 Inc groups are recognized among the Enterobac-
teriaceae family (Carattoli, 2011). Particular plasmid incompati-
bility groups are more frequently encountered among E. coli and
these play a major role in the dissemination of specific resis-
tance genes. For instance, in Netherlands, genetically related IncI1
plasmids carrying the blaCTX−M−1 gene were identified in E. coli
isolates frompoultrymeat samples and in infected individuals sug-
gesting that transfer of these plasmids may have occurred among
strains from food-producing animals and humans (Leverstein-
van Hall et al., 2011). CTX-M-1 was also identified on plasmids
belonging to the IncN family in Europe among porcine (Moodley
and Guardabassi, 2009), canine (Schink et al., 2011), and human
E. coli isolates (Novais et al., 2007). In contrast, IncFII, IncA/C,
IncL/M, IncN, and IncI1 plasmids carrying ESBL determinants
are currently considered to be epidemic resistance plasmids, being
detected in Enterobacteriaceae of different origin and sources
(Carattoli, 2011). In the study reported here, PBRT typing identi-
fied 11 of 18 replicons (including IncA/C, IncB/O, IncFIA, IncFIB,
IncFIC, IncHI1, IncP, IncK/B, IncI1, IncN, and IncY). IncFIB,
IncK/B, and IncI1 were the more commonly identified replicon
families in this study with 67% (n = 8) being IncI1 plasmids and
which were isolated from the poultry samples. Moreover, con-
jugative transfer of plasmids belonging to incompatibility groups
IncI1, IncFIB, and, less frequently, IncN, IncB/O, and IncP could
be demonstrated under laboratory conditions, suggesting that the
potential dissemination of these markers may exist in the wildlife
(Figure 2). This observation is interesting given that plasmids
of IncI (both IncI1 and IncI2) and IncF groups are commonly
recovered from E. coli and Salmonella species cultured from both
animals and humans, and they are also linked to a number of genes
coding for ESBL-genotypes (Johnson et al., 2007; Carattoli, 2009;
Doumith et al., 2012).
IncI1 plasmids are often associated with resistance to mul-
tiple antimicrobial compounds, particularly extended-spectrum
cephalosporinases of both the CTX-M and CMY types (Hop-
kins et al., 2006; Marcade et al., 2009). These have also been
linked to TEM-52 enzymes. IncI1 plasmids producing TEM-52
have been identified in E. coli cultured from chicken and turkey
meat in Denmark and the UK (Jensen et al., 2006; Randall et al.,
2011). Interestingly an IncI1 plasmid carrying blaCTX−M−15 and
blaTEM−1 was associated with the recent 2011 outbreak of the E.
coli O104:H4 in Germany2. Three conjugative IncI1 plasmids were
identified among the E. coli isolates in this study. One such plas-
mid was from a healthy chicken isolate and contained a blaTEM−52
marker. Others may lead to the transfer of blaCTX−M−1 (Figure 2).
These findings further support the suggestion that there may be
prevalent plasmid types that are responsible for the dissemination
of specific resistance genes in E. coli causing both community- and
hospital-acquired infections (Sherley et al., 2003; Hopkins et al.,
2006; Novais et al., 2007).
IncF replicons (including FIA, FIB, and FIC) were the most
frequently detected replicon types in the studied collection (45%).
2www.efsa.europa.eu/en/efsajournal/doc/2274.pdf
Interestingly, no IncFII typewas identified. These data are in accor-
dance with the previous reports (Johnson et al., 2007; Marcade
et al., 2009). IncF replicons are widely distributed among E. coli
and these plasmid types seem to be well adapted to this species.
Three large potential conjugative plasmids (100- to 150-kb) of
IncFIB replicon type were identified. This finding supports the
view that IncF family plasmids play a major role in the dissem-
ination of antibiotic resistance in Enterobacteriaceae, and some
have been associated with specific genes conferring resistance to
aminoglycosides, β-lactams, and quinolones (Hopkins et al., 2006;
Marcade et al., 2009). Plasmids of the IncP group are recognized
as a significant antibiotic resistance marker reservoir due to their
self-transmissibility and broad host range (Schluter et al., 2007).
Only a single possible conjugative IncP plasmid was identified
among the transmissible plasmids studied. A similar situation was
noted for the IncB/O type. This feature was interesting, given the
fact that in previous studies IncP and IncB/O were the dominant
Inc-types identified among transmissible plasmids characterized
(Karczmarczyk et al., 2011).
β-Lactamase-encoding (bla) genes have benefited from the var-
ious mechanisms available to promote HGT between bacteria,
thereby ensuring the spread of these markers to new hosts. It
is often included as component parts of multi-resistance plasmids
commonly found in clinical isolates (Bush and Jacoby,2010). Iden-
tification of the resistance genes together with an investigation of
their potential for dissemination among bacteria of animal origin
provides valuable insights into this important resistance gene pool
(Norman et al., 2009). Use of extended-spectrum cephalosporins,
in animal and human medicine can select for ESBL-genotypes.
Dating back to the late 1990s, CTX-M enzymes are regarded
as the predominant ESBL-types of animal origin as well as in
human isolates in Europe (Livermore et al., 2007). As TEM-1 is the
most commonplasmid-mediated β-lactamase identified in enteric
Gram-negative bacilli, high rates of ampicillin-resistant, blaTEM-
positive isolates are to be expected (Paterson and Bonomo, 2005).
In the current study, the blaCTX−M−1 gene was identified in eight
transconjugants (including four from healthy humans, three from
chickens, and one from a lamb; Figure 2). The blaTEM−1 gene was
also identified in five transconjugants (four from healthy humans
and one from a chicken sample; Figure 2). To our knowledge,
neither blaCTX−M−1 nor blaTEM−1 associated with conjugative
plasmids has been reported in healthy humans or food-producing
animals in Switzerland.
In the laboratory, cefotaxime is used for optimum detection of
blaESBL-encoding isolates aiding in the identification of CTX-M
carrying bacteria (Rodriguez et al., 2006). In this study, cefotaxime
resistance was observed to occur concomitantly with resistance to
AMP/KF/CPD in eight transconjugants and this feature could be
linked directly to the presence of blaCTX−M−1 (in eight of nine
transconjugants), to blaTEM−1 (in five isolates), and to blaTEM−52
(in one isolate). However, only one –isolate showed resistance to
amoxicillin–clavulanic acid (H-1519). As no evidence for mecha-
nistic resistance, such as the expression of inhibitor-resistant TEM
or SHV enzymes of the Bush–Jacoby groups 2be or 2ber (Bush
and Jacoby, 2010) was detected (data not shown), this phenotype
was most likely due to the hyper-expression of co-linear TEM-1
markers (Ortega et al., 2012; Zurfluh et al., 2013). Interestingly, the
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MICs of cefotaxime of three transconjugants [C-23-(T); C-49-(T)
and C-59-(T), Figure 2] were between 2- and 2.7-fold higher than
the corresponding donor strains. These increases indicated that an
amplification of multiple copies of the ESBL gene or occurrence
of a point mutation in one gene copy might increase specific activ-
ity of β-lactamase or downregulate its cell wall porins to increase
resistance (Tenover, 2006; Sun et al., 2009).
All nine transconjugants showed phenotypic resistance to more
than one class of antimicrobial compound. One isolate [H-
1038-(T); Figure 2] was found to be resistant to members of
four different drug classes (aminoglycosides, chloramphenicol,
sulfamethoxazole/trimethoprim, and tetracycline), and a fur-
ther three [H-2291-(T), H-2332-(T) and C-59-(T), Figure 2]
were resistant to three different antimicrobial compound classes
(aminoglycosides, sulfamethoxazole/trimethoprim, and tetracy-
cline or chloramphenicol). To our knowledge, this is the first evi-
dence of this emergingmulti-resistant clonewith large conjugative
plasmids from healthy humans and animals in Switzerland.
Recently, ESBL-producing E. coli ST131 and ST1722 were
cultured from rivers and lakes (Zurfluh et al., 2013) and ST61
was recovered from slaughterhouses (Endimiani et al., 2012) in
Switzerland. Furthermore, ESBL-producing E. coli ST57 and
ST371 were cultured from chickens in the UK, Germany, and
Canada (Randall et al., 2011). Of the nine donor strains inves-
tigated in this study, the clonal lineages detected among healthy
humans included phylogroup B1-O8:H21-unknown ST type,
phylogroup A-O53:H18-ST1638, a pathogenic phylogroup D-
O24:H26-ST57/ST350 complex, and phylogroup A-O2:H48-ST10
complex. Among the five animal isolates the lineages included
phylogroup B1-O3:Hnt-ST1389, phylogroup B1-Ont:H21-ST446
complex, phylogroup B1-O68:H21-ST3174 complex, phylogroup
B1-O86:H51-ST155 complex, and phylogroup D-Ont:H11-ST295
from a lamb source (Table 1). Our study represents the first report
of ESBL-producing E. coli of nine different ST types from animals
and humans in Switzerland. Interestingly, these showed a distribu-
tion of plasmid replicon types similar to those reported previously
in unselectedE. coli, whereas in contrast the distribution of STswas
markedly different (EFSA Panel on Biological Hazards [BIOHAZ],
2011; Randall et al., 2011). These finding may indicate the pres-
ence of systems affecting the incorporation and/or maintenance
of antibiotic resistance genes not related to plasmid restriction
(Bengtsson et al., 2012).
Characterizing plasmids from bacteria of different origins
may provide early insights into the epidemiology of important
resistance markers, including ESBL-determinants. Few studies
have provided clear evidence of a direct transmission of ESBL-
producing E. coli isolates from food-producing animals and/or
food tohumans. Nonetheless, these data showed thatMDRpheno-
types, including resistance to newer generations of antimicrobial
compounds, were transferable and in some cases were directly
linked to large conjugative plasmids carrying multiple resistance
genes. This situation could, in the future give rise to the co-
selection, promoting the dissemination of ESBL-genotypes among
bacteria of healthy food-producing animal and human origins
alike.
ACKNOWLEDGMENTS
We thank Jørger Leisner (Department of Veterinary Pathobiology,
Faculty of Life Sciences,University of Copenhagen) for kindly pro-
viding the reference strains, E. coli 39R 861, for determining the
molecular mass of plasmids. The recipient strain used in conju-
gation assays, E. coli 26R 793 (Rifr, lac negative), was a gift from
Dr. Vivi Miriagou (Laboratory of Bacteriology, Hellenic Pasteur
Institute, Athens, Greece).
REFERENCES
Barton, B. M., Harding, G. P., and Zuc-
carelli, A. J. (1995). A general method
for detecting and sizing large plas-
mids. Anal. Biochem. 226, 235–240.
doi: 10.1006/abio.1995.1220
Bengtsson, S., Naseer, U., Sundsfjord,
A., Kahlmeter, G., and Sundqvist,
M. (2012). Sequence types and
plasmid carriage of uropathogenic
Escherichia coli devoid of phenotypi-
cally detectable resistance. J. Antimi-
crob. Chemother. 67, 69–73. doi:
10.1093/jac/dkr421
Boyd, E. F., Hill, C. W., Rich, S. M., and
Hartl, D. L. (1996). Mosaic structure
of plasmids from natural popula-
tions of Escherichia coli. Genetics 143,
1091–1100.
Bush, K. (2010). Bench-to-bedside
review: the role of beta-lactamases
in antibiotic-resistant Gram-negative
infections. Crit. Care 14, 224. doi:
10.1186/cc8892
Bush, K., and Jacoby, G. A. (2010).
Updated functional classification of
beta-lactamases. Antimicrob. Agents
Chemother. 54, 969–976. doi:
10.1128/AAC.01009-09
Carattoli, A. (2009). Resistance plas-
mid families in Enterobacteriaceae.
Antimicrob. Agents Chemother. 53,
2227–2238. doi: 10.1128/AAC.
01707-08
Carattoli, A. (2011). Plasmids in
Gram negatives: molecular typ-
ing of resistance plasmids. Int. J.
Med. Microbiol. 301, 654–658. doi:
10.1016/j.ijmm.2011.09.003
Carattoli, A., Bertini, A., Villa, L., Falbo,
V., Hopkins, K. L., and Threlfall,
E. J. (2005). Identification of plas-
mids by PCR-based replicon typing.
J. Microbiol. Methods 63, 219–228.
doi: 10.1016/j.mimet.2005.03.018
Clermont, O., Bonacorsi, S., and Bin-
gen, E. (2000). Rapid and sim-
ple determination of the Escherichia
coli phylogenetic group. Appl. Env-
iron. Microbiol. 66, 4555–4558.
doi: 10.1128/AEM.66.10.4555-4558.
2000
CLSI. (2011). Performance Standards
for Antimicrobial Susceptibility Test-
ing: 21st Informational Supplement.
CLSI Document M100-S21. Wayne,
PA: Clinical and Laboratory Stan-
dards Institute.
Coque, T. M., Baquero, F., and Canton,
R. (2008). Increasing prevalence of
ESBL-producing Enterobacteriaceae
in Europe. Euro. Surveill. 13.
Doumith, M., Dhanji, H., Ellington,
M. J., Hawkey, P., and Woodford, N.
(2012). Characterization of plasmids
encoding extended-spectrum beta-
lactamases and their addiction sys-
tems circulating among Escherichia
coli clinical isolates in the UK. J.
Antimicrob. Chemother. 67, 878–885.
doi: 10.1093/jac/dkr553
EFSA Panel on Biological Hazards
(BIOHAZ). (2011). Scientific opin-
ion on the public health risks of
bacterial strains producing extended-
spectrum β-lactamases and/orAmpC
β-lactamases in food and food-
producing animals. EFSA J. 9, 2322.
doi: 10.2903/j.efsa.2011.2322
Endimiani, A., Rossano, A., Kunz, D.,
Overesch, G., and Perreten,V. (2012).
First countrywide survey of third-
generation cephalosporin-resistant
Escherichia coli from broilers, swine,
and cattle in Switzerland. Diagn.
Microbiol. Infect. Dis. 73, 31–38. doi:
10.1016/j.diagmicrobio.2012.01.004
Foxman, B. (2013). Editorial com-
mentary: extended-spectrum beta-
lactamase-producing Escherichia coli
in the United States: time to rethink
empirical treatment for suspected E.
coli infections? Clin. Infect. Dis. 56,
649–651. doi: 10.1093/cid/cis947
Garcillan-Barcia, M. P., Alvarado, A.,
and De La Cruz, F. (2011). Identi-
fication of bacterial plasmids based
on mobility and plasmid popula-
tion biology. FEMS Microbiol. Rev.
35, 936–956. doi: 10.1111/j.1574-
6976.2011.00291.x
Geser, N., Stephan, R., and Hachler,
H. (2012a). Occurrence and char-
acteristics of extended-spectrum
beta-lactamase (ESBL) producing
Enterobacteriaceae in food produc-
ing animals, minced meat and raw
milk. BMC Vet. Res. 8, 21. doi:
10.1186/1746-6148-8-21
Geser, N., Stephan, R., Korczak,
B. M., Beutin, L., and Hachler,
H. (2012b). Molecular identifi-
cation of extended-spectrum-beta-
lactamase genes from Enterobacteri-
aceae isolated from healthy human
carriers in Switzerland. Antimicrob.
www.frontiersin.org July 2013 | Volume 4 | Article 188 | 7
“fmicb-04-00188” — 2013/7/10 — 13:54 — page 8 — #8
Wang et al. Extended-spectrum-β-lactamase-producing Enterobacteriaceae
Agents Chemother. 56, 1609–1612.
doi: 10.1128/AAC.05539-11
Harajly, M., Khairallah, M. T., Corkill,
J. E., Araj, G. F., and Matar,
G. M. (2010). Frequency of con-
jugative transfer of plasmid-encoded
ISEcp1 – blaCTX-M-15 and aac(6′)-
lb-cr genes in Enterobacteriaceae at a
tertiary care center in Lebanon – role
of transferases. Ann. Clin. Microbiol.
Antimicrob. 9, 19. doi: 10.1186/1476-
0711-9-19
Hopkins, K. L., Liebana, E., Villa,
L., Batchelor, M., Threlfall, E. J.,
and Carattoli, A. (2006). Repli-
con typing of plasmids carrying
CTX-M or CMY beta-lactamases
circulating among Salmonella and
Escherichia coli isolates. Antimicrob.
Agents Chemother. 50, 3203–3206.
doi: 10.1128/AAC.00149-06
Jensen, L. B., Hasman, H., Agerso, Y.,
Emborg, H. D., and Aarestrup, F.
M. (2006). First description of an
oxyimino-cephalosporin-resistant,
ESBL-carrying Escherichia coli iso-
lated from meat sold in Denmark. J.
Antimicrob. Chemother. 57, 793–794.
doi: 10.1093/jac/dkl048
Johnson, T. J., Wannemuehler, Y.
M., Johnson, S. J., Logue, C.
M., White, D. G., Doetkott, C.,
et al. (2007). Plasmid replicon typ-
ing of commensal and pathogenic
Escherichia coli isolates. Appl. Envi-
ron. Microbiol. 73, 1976–1983. doi:
10.1128/AEM.02171-06
Karczmarczyk, M., Walsh, C., Slowey,
R., Leonard, N., and Fanning, S.
(2011). Molecular characterizationof
multidrug-resistant Escherichia coli
isolates from Irish cattle farms. Appl.
Environ. Microbiol. 77, 7121–7127.
doi: 10.1128/AEM.00601-11
Leverstein-van Hall, M. A., Dierikx,
C. M., Cohen Stuart, J., Voets, G.
M., Van Den Munckhof, M. P., Van
Essen-Zandbergen, A., et al. (2011).
Dutch patients, retail chicken meat
and poultry share the same ESBL
genes, plasmids and strains. Clin.
Microbiol. Infect. 17, 873–880. doi:
10.1111/j.1469-0691.2011.03497.x
Livermore, D. M., Canton, R., Gniad-
kowski, M., Nordmann, P., Rossolini,
G. M., Arlet, G., et al. (2007). CTX-
M: changing the face of ESBLs in
Europe. J. Antimicrob. Chemother. 59,
165–174. doi: 10.1093/jac/dkl483
Macrina, F. L., Kopecko, D. J.,
Jones, K. R., Ayers, D. J., and
Mccowen, S. M. (1978). A mul-
tiple plasmid-containing Escherichia
coli strain: convenient source of size
reference plasmid molecules. Plas-
mid 1, 417–420. doi: 10.1016/0147-
619X(78)90056-2
Marcade, G., Deschamps, C., Boyd, A.,
Gautier, V., Picard, B., Branger, C.,
et al. (2009). Replicon typing of plas-
mids in Escherichia coli producing
extended-spectrum beta-lactamases.
J. Antimicrob. Chemother. 63, 67–71.
doi: 10.1093/jac/dkn428
Moodley, A., and Guardabassi, L.
(2009). Transmission of IncN
plasmids carrying bla(CTX-M-1)
between commensal Escherichia coli
in pigs and farm workers. Antimicrob.
Agents Chemother. 53, 1709–1711.
doi: 10.1128/AAC.01014-08
Norman, A., Hansen, L. H., and
Sorensen, S. J. (2009). Conjugative
plasmids: vessels of the communal
gene pool. Philos. Trans. R. Soc. Lond.
B Biol. Sci. 364, 2275–2289. doi:
10.1098/rstb.2009.0037
Novais, A., Canton, R., Moreira, R.,
Peixe, L., Baquero, F., and Coque, T.
M. (2007). Emergence and dissemi-
nation of Enterobacteriaceae isolates
producing CTX-M-1-like enzymes
in Spain are associated with IncFII
(CTX-M-15) and broad-host-range
(CTX-M-1, -3, and -32) plas-
mids. Antimicrob. Agents Chemother.
51, 796–799. doi: 10.1128/AAC.
01070-06
Ortega, A., Oteo, J., Aranzamendi-
Zaldumbide, M., Bartolome, R. M.,
Bou, G., Cercenado, E., et al. (2012).
Spanish multicenter study of the
epidemiology and mechanisms of
amoxicillin-clavulanate resistance in
Escherichia coli. Antimicrob. Agents
Chemother. 56, 3576–3581. doi:
10.1128/AAC.06393-11
Paterson, D. L., and Bonomo, R.
A. (2005). Extended-spectrum beta-
lactamases: a clinical update. Clin.
Microbiol. Rev. 18, 657–686. doi:
10.1128/CMR.18.4.657-686.2005
Randall, L. P., Clouting, C., Horton, R.
A., Coldham, N. G., Wu, G., Clifton-
Hadley, F. A., et al. (2011). Prevalence
of Escherichia coli carrying extended-
spectrum beta-lactamases (CTX-M
and TEM-52) from broiler chick-
ens and turkeys in Great Britain
between 2006 and 2009. J. Antimi-
crob. Chemother. 66, 86–95. doi:
10.1093/jac/dkq396
Rodriguez, I., Rodicio, M. R., Men-
doza, M. C., and Cruz Martin, M.
(2006). Large conjugative plasmids
from clinical strains of Salmonella
enterica serovar Virchow contain a
class 2 integron in addition to
class 1 integrons and several non-
integron-associated drug resistance
determinants. Antimicrob. Agents
Chemother. 50, 1603–1607. doi:
10.1128/AAC.50.4.1603-1607.2006
Rogers, B. A., Sidjabat, H. E., and Pater-
son, D. L. (2011). Escherichia coli
O25b-ST131: a pandemic,multiresis-
tant, community-associated strain. J.
Antimicrob. Chemother. 66, 1–14. doi:
10.1093/jac/dkq415
Schink, A. K., Kadlec, K., and
Schwarz, S. (2011). Analysis of
bla(CTX-M)-carrying plasmids from
Escherichia coli isolates collected in
the BfT-GermVet study. Appl. Envi-
ron. Microbiol. 77, 7142–7146. doi:
10.1128/AEM.00559-11
Schluter, A., Szczepanowski, R., Puhler,
A., and Top, E. M. (2007). Genomics
of IncP-1 antibiotic resistance plas-
mids isolated from wastewater treat-
ment plants provides evidence for
a widely accessible drug resistance
gene pool. FEMS Microbiol. Rev.
31, 449–477. doi: 10.1111/j.1574-
6976.2007.00074.x
Sherley, M., Gordon, D. M., and Col-
lignon, P. J. (2003). Species dif-
ferences in plasmid carriage in the
Enterobacteriaceae. Plasmid 49, 79–
85. doi: 10.1016/S0147-619X(02)
00107-5
Smillie, C., Garcillan-Barcia, M. P.,
Francia,M.V., Rocha, E. P., and De La
Cruz, F. (2010). Mobility of plasmids.
Microbiol. Mol. Biol. Rev. 74, 434–
452. doi: 10.1128/MMBR.00020-10
Stalder, T., Barraud, O., Casellas, M.,
Dagot, C., and Ploy, M. C. (2012).
Integron involvement in environ-
mental spread of antibiotic resis-
tance. Front. Microbiol 3:119. doi:
10.3389/fmicb.2012.00119
Sun, S., Berg, O. G., Roth, J. R., and
Andersson, D. I. (2009). Contribu-
tion of gene amplification to evolu-
tion of increased antibiotic resistance
in Salmonella typhimurium. Genetics
182, 1183–1195. doi: 10.1534/genet-
ics.109.103028
Tenover, F. C. (2006). Mechanisms
of antimicrobial resistance in bacte-
ria. Am. J. Med. 119, S3–S10. doi:
10.1016/j.amjmed.2006.03.011
van Hoek, A. H., Mevius, D.,
Guerra, B., Mullany, P., Roberts,
A. P., and Aarts, H. J. (2011).
Acquired antibiotic resistance genes:
an overview. Front Microbiol 2:203.
doi: 10.3389/fmicb.2011.00203
Williams, L. E., Wireman, J., Hilliard,
V. C., and Summers, A. O. (2013).
Large plasmids of Escherichia coli
and Salmonella encode highly diverse
arrays of accessory genes on com-
mon replicon families. Plasmid 69,
36–48. doi: 10.1016/j.plasmid.2012.
08.002
Wirth, T., Falush, D., Lan, R.,
Colles, F., Mensa, P., Wieler, L. H.,
et al. (2006). Sex and virulence in
Escherichia coli: an evolutionary per-
spective. Mol. Microbiol. 60, 1136–
1151. doi: 10.1111/j.1365-2958.2006.
05172.x
Zhou, Y. Y., Call, D. R., and Broschat,
S. L. (2012). Genetic relationships
among 527 Gram-negative bacterial
plasmids. Plasmid 68, 133–141. doi:
10.1016/j.plasmid.2012.05.002
Zurfluh, K., Hächler, H., Nuesch-
Inderbinen, M., and Stephan, R.
(2013). Characteristics of extended-
spectrum beta-lactamase (ESBL)-
and carbapenemase-producing
Enterobacteriaceae isolated from
rivers and lakes in Switzerland. Appl.
Environ. Microbiol. 79, 3021–3026.
doi: 10.1128/AEM.00054-13
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 21 May 2013; accepted: 20 June
2013; published online: 11 July 2013.
Citation: Wang J, Stephan R, Karcz-
marczyk M, Yan Q, Hächler H and
Fanning S (2013) Molecular characteri-
zation of blaESBL-harboring conjugative
plasmids identified in multi-drug resis-
tant Escherichia coli isolated from food-
producing animals and healthy humans.
Front. Microbiol. 4:188. doi: 10.3389/
fmicb.2013.00188
This article was submitted to Fron-
tiers in Antimicrobials, Resistance and
Chemotherapy, a specialty of Frontiers in
Microbiology.
Copyright © 2013 Wang, Stephan, Kar-
czmarczyk, Yan, Hächler and Fanning.
This is an open-access article distributed
under the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy July 2013 | Volume 4 | Article 188 | 8
“fmicb-04-00188” — 2013/7/10 — 13:54 — page 9 — #9
Wang et al. Extended-spectrum-β-lactamase-producing Enterobacteriaceae
APPENDIX
FIGUREA1 | A heat-map summary of the original 87 ESBL-positive
E. coli isolates previously reported from healthy food-producing
animals and humans in Switzerland. Black squares shown indicate a
feature present in that isolate denoting its original source and the ESBL
marker(s) detected; and white squares denote features that are lacking in
the corresponding bacterial isolate. The approximate sizes of small
plasmids are also showing in separate columns. The symbol “–” signifies
no small (<30-kb) plasmid in the corresponding strain. Isolate numbers
denoted by the grayed boxes on the left of the heat-map indicate those
bacteria that were selected for conjugation experiments and
S1-nuclease-based PFGE studies (as described in Figure 1).
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